21 Jul 2011 BioSante Pharmaceuticals Signs Melanoma Vaccine License
20 Jul 2011 Dynavax Phase 3 Demonstrates Superiority and Safety of HEPLISAV(TM) vs. Engerix-B(R)
20 Jul 2011 Aeterna Zentaris Successfully Reached a Key Milestone in the Non-Clinical Development of its Oral Prostate Cancer Vaccine Candidate, AEZS-120
18 Jul 2011 Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS' HIV Vaccine VRX1273
18 Jul 2011 SEEK Announces Clinical Proof of Efficacy in HIV Vaccine Phase Ib/II Human Trial
18 Jul 2011 Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial
15 Jul 2011 Inovio Pharmaceuticals Demonstrates T Cell Immune Response Durability with Fourth Dose of Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
14 Jul 2011 Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
14 Jul 2011 Vical and Astellas Announce Worldwide License Agreements for TransVax(TM) Cytomegalovirus Vaccine
14 Jul 2011 GlaxoSmithKline and Human Genome Sciences Receive European Authorization for BENLYSTA (Belimumab)
14 Jul 2011 Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee in Favor of Accelerated Approval of ADCETRIS for Post-Transplant Relapsed Hodgkin Lymphoma and Relapsed or Refractory Systemic ALCL
14 Jul 2011 YERVOY (ipilimumab) Approved for the Treatment of Previously-Treated Advanced Melanoma in the EU
11 Jul 2011 Advaxis Completes Enrollment of Low Dose Cohort in CIN Study
11 Jul 2011 GlaxoSmithKline (GSK) Receives FDA Approval for BOOSTRIX to Help Prevent Whooping Cough in Adults 65 Years and Older
07 Jul 2011 Inovio Expands DNA Vaccine Intellectual Property License With the University of Pennsylvania
05 Jul 2011 Inovio Pharmaceuticals Synthetic DNA Vaccine Protects Against HIV in Non-Human Primates
04 Jul 2011 Sorrento Therapeutics' Innovative Approach to Developing Vaccines and Therapeutics for MRSA Receives Continued Support From the National Institute of Allergy and Infectious Diseases
30 Jun 2011 Scancell Develops New Vaccine for the Treatment of Lung Cancer
30 Jun 2011 Inovio Pharmaceuticals' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
30 Jun 2011 Medicago reports positive Phase II final results for its avian flu pandemic vaccine
29 Jun 2011 Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
28 Jun 2011 VaxyGen Vaccines Ltd. Announces Exclusive Strategic Vaccine Collaboration with The Serum Institute of India (SII)
28 Jun 2011 Vical Provides Allovectin(R) and Herpes Simplex Vaccine Updates at BIO International Convention
28 Jun 2011 Diamyd Medical: Diamyd Presents Detailed Results of European Phase III Study

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up